Multiple biomarkers improve diagnostic accuracy across Lewy body and Alzheimer's disease spectra.
Melanie J PlastiniCarla AbdelnourChristina B YoungEdward N WilsonMarian Shahid-BesantiJennifer LamoureuxKatrin I AndreassonGeoffrey A KerchnerThomas J MontineVictor W HendersonKathleen L PostonPublished in: Annals of clinical and translational neurology (2024)
Our study shows that using a combination of αSyn-SAA and AD biomarkers can identify people with αSyn, ADNC, and co-pathology better and earlier than traditional clinical diagnostic criteria alone.